Beating SIBO for Good: A Tailored Approach to Testing, Treatment, and Long-Term Gut Health

by | Aug 14, 2025 | Home Page Display

SIBO treatment functional

Beating SIBO: A Tailored Functional Medicine Approach to Testing, Treatment, and Long-Term Gut Health

Author: Rohan Smith | Functional Medicine Practitioner | Adelaide, SA

Quick Answer

Small Intestinal Bacterial Overgrowth (SIBO) is a condition characterised by excessive bacterial colonisation of the small intestine, which can interfere with digestion and nutrient absorption. While dietary strategies may help reduce symptoms, long-term management of SIBO typically requires accurate testing, targeted antimicrobial treatment, support for gut motility, and structured gut repair. A functional medicine approach focuses on identifying contributing factors and reducing the risk of recurrence rather than offering a guaranteed cure (1,2).

What Is SIBO?

SIBO occurs when bacteria that normally reside in the large intestine accumulate in the small intestine, where bacterial levels are usually much lower. This overgrowth can lead to fermentation of carbohydrates, gas production, inflammation, and impaired absorption of nutrients. Common symptoms include bloating, abdominal discomfort, diarrhoea or constipation, reflux, and fatigue (3).

The Role of Breath Testing in Diagnosing SIBO

Breath testing is the most widely used non-invasive tool for identifying SIBO. After ingestion of a glucose or lactulose solution, breath samples are collected to measure hydrogen and methane gases produced by bacterial fermentation. These results help determine whether SIBO is hydrogen-dominant, methane-dominant, or mixed, which may guide treatment selection (4,5).

Breath testing also provides insight into symptom patterns and helps clinicians avoid unnecessary or poorly targeted treatments.

Why Diet Alone Is Often Not Enough

Low-FODMAP or carbohydrate-restricted diets are commonly used to reduce bloating and gas by limiting fermentable substrates. While these approaches can improve symptoms in the short term, they do not directly address bacterial overgrowth and are not intended as permanent solutions (6).

Prolonged dietary restriction without addressing underlying contributors may negatively affect the gut microbiome and overall nutritional status.

Targeted Antimicrobial Treatment

Antimicrobial therapy may be considered following positive breath test results. Treatment selection is typically guided by gas type and symptom profile:

  • Prescription antibiotics, such as rifaximin or rifaximin combined with neomycin, may be used under medical supervision depending on hydrogen or methane predominance (7,8).
  • Herbal antimicrobials, including berberine or oregano-based formulations, may be considered as alternatives in some cases (9).

Personalisation is important, as individual responses and tolerance can vary. Antimicrobials are not intended to be used indefinitely.

Supporting Gut Motility to Reduce Recurrence Risk

Impaired gastrointestinal motility is a recognised contributor to SIBO recurrence. The migrating motor complex (MMC) helps clear bacteria from the small intestine between meals. Disruption of this process can allow bacteria to persist or return (10).

Strategies to support motility may include:

  • Prokinetic agents, prescribed or nutritionally supported, when clinically appropriate
  • Meal spacing and regular movement
  • Stress management, given the relationship between the stress response and gut function

Assessment of stress physiology, including tools such as an adrenal function assessment, may be relevant for some individuals.

Gut Repair and Functional Support

Following antimicrobial therapy, gut repair aims to support intestinal barrier function, digestion, and microbial balance. This phase may include:

  • Nutrients such as glutamine or zinc to support intestinal integrity (11)
  • Selective probiotic use, depending on tolerance and symptom pattern (12)
  • Digestive enzymes or bile support where malabsorption is suspected

In some cases, broader functional testing, such as organic acid testing or comprehensive microbiome analysis, may help identify metabolic or microbial factors influencing recovery.

When to Consider SIBO Testing

  • Persistent bloating or abdominal discomfort despite dietary changes
  • IBS-like symptoms that relapse after treatment
  • Nutrient deficiencies or unexplained chronic fatigue

Frequently Asked Questions

Can SIBO come back after treatment?

Yes. Recurrence is relatively common, particularly if underlying contributors such as impaired gut motility, unresolved stress, or dietary factors are not addressed. Long-term management focuses on reducing recurrence risk rather than providing a one-time cure.

Are probiotics always recommended for SIBO?

Not always. Some people tolerate probiotics well, while others experience increased bloating or discomfort. The type of probiotic, timing, and individual symptom pattern all matter, which is why probiotic use is often personalised.

Is breath testing necessary to diagnose SIBO?

Breath testing is currently the most widely used non-invasive method for assessing SIBO and helps distinguish between hydrogen- and methane-dominant patterns. While symptoms can raise suspicion, testing improves diagnostic clarity and helps guide more targeted treatment decisions.

Key Insights

  • SIBO involves bacterial overgrowth in the small intestine, not just food intolerance
  • Breath testing helps guide targeted treatment decisions
  • Motility support is critical for reducing recurrence risk
  • Gut repair and functional assessment support long-term digestive health

How Functional Medicine in Adelaide May Help

At Elemental Health and Nutrition in Adelaide, SIBO management focuses on assessment-led care, education, and personalised strategies. Functional medicine does not promise cures but aims to support gut health by addressing contributing factors and improving long-term resilience.

Book a free 15min Discovery Call

References

  1. Rezaie A, et al. Hydrogen and methane-based breath testing in gastrointestinal disorders. Am J Gastroenterol. 2017.
  2. Pimentel M, et al. Small intestinal bacterial overgrowth: pathogenesis and management. Gastroenterology. 2020.
  3. Ghoshal UC, et al. Small intestinal bacterial overgrowth and IBS. Gut Liver. 2017.
  4. Quigley EMM, et al. Breath testing for SIBO. Clin Gastroenterol Hepatol. 2019.
  5. Saad RJ, et al. Lactulose breath testing interpretation. Neurogastroenterol Motil. 2014.
  6. Staudacher HM, et al. Low-FODMAP diet mechanisms and limitations. Gut. 2017.
  7. Pimentel M, et al. Rifaximin therapy for SIBO. N Engl J Med. 2011.
  8. Low K, et al. Methane-associated constipation and treatment. Dig Dis Sci. 2010.
  9. Chedid V, et al. Herbal therapy in SIBO. Glob Adv Health Med. 2014.
  10. Deloose E, et al. The migrating motor complex. Nat Rev Gastroenterol Hepatol. 2012.
  11. Rao SSC, et al. Intestinal permeability and nutrient support. Clin Gastroenterol Hepatol. 2020.
  12. Didari T, et al. Probiotics in functional gastrointestinal disorders. World J Gastroenterol. 2015.
  13. Weinstock LB, et al. SIBO recurrence patterns. Dig Dis Sci. 2021.
  14. Ford AC, et al. IBS, gut microbiota, and SIBO overlap. BMJ. 2020.
  15. Camilleri M. Gut motility and functional bowel disorders. Gastroenterology. 2021.